869 results match your criteria: "UNIV. NIMES[Affiliation]"

In Gram-negative bacteria, resistance-nodulation-division (RND)-type efflux pumps, particularly AcrAB-TolC, play a critical role in mediating resistance to antimicrobial agents and toxic metabolites, contributing to multidrug resistance. is an entomopathogenic bacterium that has garnered significant interest due to its production of bioactive specialized metabolites with anti-inflammatory, antimicrobial, and scavenger deterrent properties. In previous work, we demonstrated that AcrAB confers self-resistance to stilbenes in TT01.

View Article and Find Full Text PDF

NIR-responsive dextran / poly(lactide) hydrogels: Characterization of cleavable hydrogels and photoactivated release of proteins.

Carbohydr Polym

November 2025

Department of Polymers for Health and Biomaterials, IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France; Department of Pharmacy, Nîmes University Hospital, 30900 Nimes, France. Electronic address:

Polysaccharide-based hydrogels often lack mechanical strength and, when used for protein delivery, are generally limited to diffusion-based release. In this work, we developed robust polysaccharide- and polyester-based near-infrared (NIR)-responsive hydrogels. Hydrogels are made from photo-crosslinked methacrylated dextran (DEX-MA), methacrylated polylactide containing oxygen reactive species (ROS) sensitive thioketal groups (PLA-TK-MA), and covalently bound protoporphyrin IX (PPIX) that generates ROS under NIR irradiation.

View Article and Find Full Text PDF

Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis.

J Neurol Neurosurg Psychiatry

September 2025

Hospices Civils de Lyon, Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuroinflammation, Bron, France.

Unlabelled: BackgroundTarget trial emulation (TTE) offers a formal framework for causal inference using observational data, but its validity must be evaluated in each research domain by replicating randomised clinical trials (RCTs). We aimed to replicate eight RCTs evaluating the efficacy of disease-modifying therapies (DMTs) in multiple sclerosis (MS) using French registry data.

Methods: This multicentre, retrospective, observational study was conducted using data extracted in December 2023 from the (OFSEP) database.

View Article and Find Full Text PDF

Musculoskeletal pain, particularly low back and neck pain, is associated with maladaptive changes in spinal motor behaviour (SMB). Psychological factors such as pain-related fear play a role in driving these adaptations. While previous research found weak associations between general psychological measures and SMB, task-specific measures may provide more precise insights into movement avoidance.

View Article and Find Full Text PDF

Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial.

Eur Heart J

August 2025

Department of Cardiology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Inserm MASCOT-UMRS 942, 2 Rue Ambroise Paré, Paris 75010, France.

Background And Aims: Despite current antithrombotic treatments, the recurrence of ischaemic events remains high in patients with diabetes mellitus (DM) or aspirin resistance after acute coronary syndrome (ACS). Whether twice-daily aspirin dosing reduces major adverse cardiovascular events (MACE) in this population remains unknown.

Methods: In this prospective multicentre, randomized trial, patients with ACS and DM or high-risk of aspirin resistance (HRAR) defined as: (i) an index event occurring while on aspirin; (ii) body mass index ≥27 kg/m2; or (iii) increased waist circumference were assigned to receive enteric-coated aspirin once daily (100 mg/day) or twice daily (100 mg morning and evening).

View Article and Find Full Text PDF

Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART study.

Vaccine

August 2025

Sorbonne université, Inserm, institut Pierre-Louis d'épidémiologie et de santé publique (IPLESP), équipe TheraVir, AP-HP, Hôpital universitaire Pitié-Salpêtrière, Oncologie médicale, CLIP(2) Galilée, Paris, France.

Background: Patients with cancer, whose immune responses to vaccines are commonly weaker than those of the general population, are recommended a booster dose after two initial doses of Covid-19 vaccine. Our objective was to compare the humoral immunogenicity of Covid-19 vaccines in patients with cancer compared to healthy adults (control group) after primary vaccine series and after a booster dose.

Methods: We included participants aged ≤75 and vaccinated with two doses in the primary vaccine series and a booster, from the French national prospective Covid-19 vaccine cohort study (ANRS0001S COV-POPART) and excluded those with SARS-CoV-2 infection.

View Article and Find Full Text PDF

Background And Aims: We compared the effectiveness of tofacitinib and ustekinumab in patients with ulcerative colitis (UC) previously exposed to at least one anti-TNF agent.

Methods: In this multicenter real-world evidence study, we consecutively included UC patients ≥18 years-old, previously exposed to anti-TNF therapy, with partial Mayo score >2 and, starting tofacitinib or ustekinumab. All the comparisons were performed using propensity score analyses.

View Article and Find Full Text PDF

Mathematical models tend to oversimplify the biological details of vaccine or infection-derived immunity effectiveness. Yet, epidemiological outcomes may diverge when assuming polarised immunity-individuals are either fully susceptible or completely immune-compared to leaky immunity-where all individuals are partially protected. We explore the differences between the two by taking advantage of a non-Markovian framework, which allows us to explicitly record the 'age' of the immunity and vary its effectiveness accordingly.

View Article and Find Full Text PDF

Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective study.

Rheumatology (Oxford)

August 2025

Sorbonne Université, AP-HP, Hôpital Pitié Salpetrière, Department of Internal Medicine and Clinical Immunology France, Centre national de référence maladies Autoimmunes Systémiques rares, Centre national de référence maladies Autoinflammatoires et Amylose, and Inflammation-Immunopathology-B

Objectives: In this large multicentre study, we aimed to compare the effectiveness of intravenous infliximab vs subcutaneous adalimumab in patients with Takayasu arteritis.

Methods: We conducted a retrospective multicentre study across referral centers in France, Italy, Spain, Armenia, Israel, Japan, Tunisia, and Russia, analyzing biological-targeted therapies in TAK from January 2017 to September 2019.

Results: A total of 135 TAK patients who received adalimumab (n = 34) or infliximab (n = 101) for at least 3 months were included.

View Article and Find Full Text PDF

Genetic testing in amyotrophic lateral sclerosis (ALS) often reveals variants of uncertain significance (VUS), which are frequently omitted from diagnostic reports or reported with limited clinical interpretation. To address this gap, we developed a rapid functional assessment pipeline in collaboration with FILSLAN, the French ALS care network, combining in vitro and in vivo neurogenetic assays. We illustrate this approach through the reclassification of the p.

View Article and Find Full Text PDF

Preclinical and clinical studies suggest an early and progressive deterioration in cerebral perfusion leading to delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH). Computed Tomography Perfusion (CTP) has then been investigated for DCI diagnosis and prognosis. However, spatial and temporal evolution of CTP-derived metrics have not been established, such that optimal CTP periodicity for monitoring and metrics thresholds for triggering intervention remain unclear.

View Article and Find Full Text PDF

Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.

JAMA Neurol

August 2025

Hospices Civils de Lyon, Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, F-69677 Bron, France.

Importance: In women with multiple sclerosis (MS), disease-modifying therapy (DMT) management during pregnancy might impact relapse risk.

Objective: To estimate the effect of DMT management during pregnancy on MS relapse rate and compare different therapeutic strategies.

Design, Setting, And Participants: This was a multicenter retrospective cohort study using data from January 1990 to December 2023.

View Article and Find Full Text PDF

Clinical impact of the BCID2 and rapid AST VITEK® REVEALTM on antibiotic optimisation in critically ill patients with Gram-negative bloodstream infections: a quasi-experimental pre/post interventional study.

J Antimicrob Chemother

August 2025

Division of Anesthesia and Critical Care, Pain and Emergency Medicine, UR-UM103 IMAGINE, Univ Montpellier, Nîmes University Hospital, Montpellier, Place du Professeur Robert Debré, 30 029 Nîmes Cedex 9, France.

Background: Rapid diagnostic tools (RDT), together with rapid antimicrobial susceptibility testing (rAST), have emerged as means to shorten the time to pathogen identification and AST for bloodstream infections (BSI). Whether these techniques significantly impact antimicrobial therapy in critically ill patients with BSI remains to be determined.

Methods: A single-center quasi-experimental study comparing antibiotic optimisation before and after the implementation of innovative RDT, BIOFIRE® Blood Culture Identification 2 (BCID2) Panel and VITEK® REVEALTM (bioMérieux), was conducted.

View Article and Find Full Text PDF

Background: Optimal antimicrobial drug exposure in the lung is required for ensuring successful treatment of community-acquired pneumonia (CAP). Little is known about the intrapulmonary pharmacokinetics (PK) of ceftobiprole when administered by continuous infusion (CI).

Objective: To determine the PK of high doses (3 g/day) CI of ceftobiprole in the plasma and epithelial lining fluid (ELF) in mechanically ventilated patients with CAP.

View Article and Find Full Text PDF

The silent surge: the under-recognised burden of respiratory syncytial virus, human metapneumovirus, and parainfluenza viruses in adults.

Int J Infect Dis

August 2025

Virulence Bactérienne et Infections Chroniques, INSERM U1047, Univ Montpellier, Service des Maladies Infectieuses et Tropicales, CHU Nîmes, Nîmes 30900, France.

Respiratory syncytial virus (RSV), human metapneumovirus (HMPV), and parainfluenza viruses (PIV) drive substantial morbidity in adults, yet remain underdiagnosed due to diagnostic gaps. While influenza and COVID-19 benefit from rapid triplex antigenic tests and PCR, HMPV and PIV lack routine diagnostics, and RSV testing is underutilised in adults, leading to frequent misdiagnosis as common colds or bacterial infections. This opinion paper highlights the burden of these "forgotten viruses" in elderly and comorbid populations, where RSV and HMPV cause significant hospitalizations.

View Article and Find Full Text PDF

Rationale: Amyotrophic Lateral Sclerosis (ALS) is a fatal motoneuron disease in which genetics plays a central role for both familial and sporadic ALS cases. Systematic genetic analysis for all ALS patients is recommended at the time of diagnosis, leading to an early proposal of specific genetic therapy. Currently, C9orf72 is considered the most frequently mutated gene in ALS.

View Article and Find Full Text PDF

Value of molecular biology tests in community-acquired acute pneumonia.

Infect Dis Now

September 2025

Virulence Bactérienne et Infections Chroniques, INSERM U1047, Univ Montpellier Department of Infectious and Tropical Disease, CHU Nîmes, Nîmes, France.

For patients hospitalized with community-acquired acute pneumonia (CAP), molecular tools (especially multiplex PCR syndromic panels) are associated with a significant improvement of microbiological diagnosis yield, compared with conventional methods. Two main families of tests are currently available: targeted viral PCR tests (influenza, SARS-CoV-2, RSV) performed on nasopharyngeal swabs and adapted to epidemic situations; and "upper respiratory tract" (nasopharyngeal) or "lower respiratory tract" (deep swabs) syndromic panels to detect a broad spectrum of viral and bacterial agents, sometimes including resistance genes. These tests are not recommended for routine use in CAP patients treated in ambulatory settings.

View Article and Find Full Text PDF

Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Neurology

August 2025

Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-inflammation, Hospices Civils de Lyon, Bron, France.

Background And Objectives: In women with multiple sclerosis (MS), the therapeutic strategy may be influenced by the anticipation of future pregnancies, leading to underexposure to disease-modifying therapies (DMTs) and highly effective DMTs (HEDMTs) compared with men. We aimed to evaluate potential therapeutic inertia in women with MS and explore its causes.

Methods: We performed a retrospective cohort study based on data extracted on June 2023 from the Observatoire Français de la Sclérose en Plaques for all patients with a relapsing-remitting MS onset between 18 and 40 years.

View Article and Find Full Text PDF

Antifungal concentrations in mechanically ventilated COVID-19 patients with or without ECMO: The CAPADOSE observational retrospective multicenter Study.

Int J Infect Dis

July 2025

AP-HP, Hôpitaux Universitaires Henri-Mondor, Créteil, France; Université Paris Est Créteil, Faculté de Médecine de Créteil, Institut Mondor de Recherche Biomédicale-Groupe de recherche clinique CARMAS, Créteil, France; Université Paris Est Créteil, INSERM, IMRB, Créteil, France.

Purpose: COVID-19-associated pulmonary aspergillosis (CAPA) is a major co-infection in critically ill patients and is linked to increased mortality. Critical illness and ECMO may affect antifungal pharmacokinetics, raising concerns about drug efficacy.

Methods: This multicenter retrospective study included CAPA patients requiring mechanical ventilation in 20 intensive care units (ICUs) (March 2020 to November 2021), provided at least one antifungal blood level was available.

View Article and Find Full Text PDF

What's new in the diagnosis and treatment of human brucellosis?

Infect Dis Now

July 2025

Virulence Bactérienne et Infections Chroniques, INSERM U1047, Univ Montpellier, Service de Microbiologie et Hygiène Hospitalière, Centre National de Reference des brucelloses, CHU Nîmes, Nîmes, France.

Brucellosis is a reemerging zoonotic infectious disease caused by Brucella spp. and posing significant global health challenges. Focusing on epidemiology, pathophysiology, diagnostic tools, and therapeutic management, the present review synthesizes recent advances in the diagnosis and treatment of brucellosis.

View Article and Find Full Text PDF

Purpose: Antimicrobial stewardship aims to improve clinical outcomes while reducing the unintended effects of antimicrobial use. The use of antibiotics in surgical wards, except for surgical antibiotic prophylaxis, has been poorly documented. Our goal was to assess the rate of compliance with the guidelines of antibiotic prescriptions in surgical wards.

View Article and Find Full Text PDF

Urban environmental and population factors as determinants of COVID-19 severity: A spatially-resolved probabilistic modeling approach.

PLOS Digit Health

July 2025

EpiDaPo Lab - CNRS/George Washington University Children's National Medical Center, Children's Research Institute, Washington, District of Columbia, United States of America.

COVID-19 is caused by a severe acute respiratory syndrome due to the SARS-CoV-2 coronavirus. It has reshaped the world with the way our communities interact, people work, commute, and spend their leisure time. While different mitigation solutions for controlling COVID-19 virus transmission have already been established, global models that would explain and predict the impact of urban environments on the case fatality ratio CFR of COVID-19 (defined as the number of deaths divided by the number of cases over a time window) are missing.

View Article and Find Full Text PDF

Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS-Park Cohort.

Mov Disord Clin Pract

July 2025

Department of Clinical Pharmacology and Neurosciences, Toulouse Parkinson Expert Centre, Toulouse NeuroToul Center of Excellence in Neurodegeneration (COEN), French NS-Park/F-CRIN Network, University of Toulouse 3, CHU of Toulouse, INSERM, Toulouse, France.

Background: Impulse control disorders (ICD) are common non-motor complications in Parkinson's disease (PD), particularly in patients receiving oral dopamine agonists (DA). Continuous subcutaneous apomorphine infusion (CSAI) is a device-aided therapy for advanced PD, but its effects on ICD remain underexplored in real-world settings.

Objectives: To assess the impact of CSAI initiation on ICD prevalence and severity in a large real-world PD cohort and to compare ICD evolution in CSAI-treated patients versus orally-treated controls.

View Article and Find Full Text PDF